Buparvaquone

Buparvaquone, an antiprotozoal drug of the hydroxynaphthoquinone group, is the single most effective drug used in the treatment of theileriosis Thirty years later buparvaquone still remains the front line commercial drug of choice for the treatment of T. parva (McHardy et al., 1985) and T. annulata infections (Dhar et al., 1986).